Inhibitor Therapeutics (INTI) Stock Chart & Stock Price History $0.05 0.00 (0.00%) As of 10/17/2025 Add Compare Share Share Chart Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Inhibitor Therapeutics Stock Price Performance The Inhibitor Therapeutics (INTI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 40.20%, with a year-to-date return of -20.40%. In the past month, the stock has increased 27.57%, reflecting recent market activity. As of the latest close, Inhibitor Therapeutics traded at $0.05 with a market cap of $8.26 million and volume of 75 shares. Five years ago, the stock traded at $0.06, representing a 13.02% decrease over that period. At the time, it had a market cap of $21.67 million and a volume of 14,850 shares. Receive INTI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibitor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance0.00%1 Month Performance+27.57%3 Month Performance-0.33%Year-To-Date Performance-20.40%1 Year PerformanceN/A5 Year Performance-13.02% INTI Stock Chart for Sunday, October, 19, 2025 INTI Chart by TradingView Inhibitor Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/17/2025$0.05$0.05$0.05$0.0575 shs$8.26 million10/15/2025$0.05$0.05$0.05$0.0575 shs$8.26 million10/14/2025$0.05$0.05$0.05$0.0510 shs$8.26 million10/10/2025$0.05$0.05$0.05$0.05500 shs$8.25 million10/09/2025$0.06$0.05-16.14%$0.05$0.05500 shs$8.25 million10/08/2025$0.06$0.06-4.68%$0.06$0.069,300 shs$9.84 million10/07/2025$0.04$0.06+49.50%$0.06$0.062,000 shs$10.32 million10/06/2025$0.05$0.04-20.00%$0.05$0.0460,100 shs$6.90 million10/03/2025$0.04$0.05+21.95%$0.06$0.05107,398 shs$8.63 million10/02/2025$0.05$0.04-17.51%$0.04$0.047,500 shs$7.08 million Get the Latest News and Ratings for INTI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inhibitor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/01/2025$0.05$0.05$0.05$0.0412,987 shs$8.58 million09/30/2025$0.05$0.05+1.84%$0.05$0.0412,987 shs$8.58 million09/29/2025$0.06$0.05-13.93%$0.05$0.05500 shs$8.42 million09/26/2025$0.06$0.06$0.06$0.0411,000 shs$9.79 million09/25/2025$0.05$0.06+13.63%$0.06$0.0411,000 shs$9.79 million09/23/2025$0.05$0.05$0.05$0.042,500 shs$8.61 million09/22/2025$0.04$0.05+33.07%$0.05$0.042,500 shs$8.61 million09/19/2025$0.04$0.04-12.79%$0.06$0.0422,983 shs$6.47 million Related Companies Rani Therapeutics Stock Chart SCYNEXIS Stock Chart HedgePath Pharmaceuticals Stock Chart ImageneBio Stock Chart Exicure Stock Chart Provectus Biopharmaceuticals Stock Chart Kezar Life Sciences Stock Chart Akari Therapeutics Stock Chart Rein Therapeutics Stock Chart Sonnet BioTherapeutics Stock Chart Receive INTI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibitor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:INTI) was last updated on 10/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibitor Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibitor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
